<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T17:49:01Z</responseDate>
  <request identifier="oai:figshare.com:article/34032552" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34032552</identifier>
        <datestamp>2026-09-30T13:12:48Z</datestamp>
        <setSpec>category_932</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Data Sheet 1_Beyond detection: developing probabilistic hemodynamic phenotyping after a positive point-of-care pulmonary hypertension test.docx</dc:title>
          <dc:creator>Farhad Fathieh (4382437)</dc:creator>
          <dc:creator>Navid Nemati (2500897)</dc:creator>
          <dc:creator>Timothy Burton (3401057)</dc:creator>
          <dc:creator>Horace R. Gillins (14123928)</dc:creator>
          <dc:creator>Ian Shadforth (5613803)</dc:creator>
          <dc:creator>Shyam Ramchandani (5613794)</dc:creator>
          <dc:creator>Charles R. Bridges (22778705)</dc:creator>
          <dc:subject>Health Informatics</dc:subject>
          <dc:subject>clinical decision support</dc:subject>
          <dc:subject>Gaussian mixture model</dc:subject>
          <dc:subject>hemodynamic phenotyping</dc:subject>
          <dc:subject>machine learning</dc:subject>
          <dc:subject>point-of-care diagnostics</dc:subject>
          <dc:subject>probabilistic classification</dc:subject>
          <dc:subject>pulmonary hypertension</dc:subject>
          <dc:description>Background&lt;p&gt;Pulmonary hypertension (PH) is a heterogeneous condition in which hemodynamic subtype directs management and specialist referral. PH can be identified non-invasively at the point of care by a previously developed, regulatory-cleared machine-learned diagnostic (area under the receiver operating characteristic curve 0.95, sensitivity 82%, specificity 92%), but a positive test result raises a second clinical question: which patients have pre-capillary disease and therefore warrant referral to a specialist PH center. A probabilistic post-test phenotyping model was developed to estimate hemodynamic subtype probabilities and support rule-out of pre-capillary PH among test-positive patients.&lt;/p&gt;Methods&lt;p&gt;Subjects with right heart catheterization (RHC)-confirmed PH [mean pulmonary artery pressure (mPAP) ≥25 mmHg] enrolled in a prospective multisite trial (NCT04031989) who tested positive on the previously validated point-of-care PH diagnostic formed the analysis cohort (n = 139). Hemodynamic subtypes were assigned per 2015 European Society of Cardiology/European Respiratory Society (ESC/ERS) criteria. A one-vs.-one (OvO) Gaussian mixture model (GMM) framework, combining unsupervised clustering with post hoc supervised assignment of subtype probabilities was applied to features derived from non-invasive orthogonal voltage gradient and photoplethysmographic signals to generate subject-level subtype probability estimates. Blinded validation in a large dataset has not yet been performed; development results are reported, supported by a small blinded independent dataset.&lt;/p&gt;Results&lt;p&gt;At an exemplar post-hoc rule-out threshold of 16% pre-capillary probability, the GMM OvO approach yielded sensitivity 86% (95% CI: 71%–95%), specificity 51% (95% CI: 41%–61%), negative predictive value 88% (95% CI: 73%–96%) at an assumed pre-capillary prevalence of 34%, and a negative likelihood ratio (LR−) of 0.27 (95% CI: 0.07–0.70) on the development cohort. Supportive out-of-sample discrimination was observed in the blinded independent cohort.&lt;/p&gt;Conclusions&lt;p&gt;A GMM OvO probabilistic model applied to non-invasive point-of-care signals can generate PH subtype probability estimates and may support rule-out of pre-capillary disease among true-positive patients. The model reuses signals already acquired for PH detection and can therefore be implemented as a software addition to an existing point-of-care workflow. Independent blinded validation is required to comprehensively characterize model performance.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-30T13:12:48Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fdgth.2026.1955810.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Data_Sheet_1_Beyond_detection_developing_probabilistic_hemodynamic_phenotyping_after_a_positive_point-of-care_pulmonary_hypertension_test_docx/34032552</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
